Articles on RNA & DNA Technologies

Advancements in RNA and DNA technologies are shaping the future of genetic therapies and diagnostics. This category covers the latest biotech applications, from gene synthesis to RNA-based therapeutics, driving innovation in the life sciences.



Featured Article

BsaI and T7 RNA Polymerase of KACTUS Pass FDA DMF Filing

After successful completion of DMF filings for our CRISPR Cas9 enzyme and Maxnuclease in the first half of 2022, we are excited to add two new products to that list. Our BsaI restriction enzyme and T7 RNA Polymerase, both from our in vitro mRNA synthesis series, have successfully passed FDA DMF filing (#037503 and #037660, respectively). 

Browse articles by topic:

Optimizing Large-scale Circular RNA Production Process with KACTUS Engineered RNase R

March 13, 2025

9 min read

Case Study: KACTUS T7 RNA Polymerase Enzyme Demonstrates Superior Performance in Independent Study

February 7, 2025

4 min read

The Ideal Choice for Low dsRNA: MaxPure™ T7 RNA Polymerase

July 16, 2024

7 min read

Engineered T7 RNA Polymerase to Reduce dsRNA

May 24, 2023

1 min read

Full Portfolio of In Vitro mRNA Synthesis Enzymes Submitted to FDA Drug Master Files (DMF)

April 23, 2023

2 min read

BsaI and T7 RNA Polymerase of KACTUS Pass FDA DMF Filing

January 4, 2023

2 min read